Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2025-12-26 @ 12:31 AM
NCT ID:
NCT02614560
Group ID:
EG000
Title:
Pre-allo (Before Stem Cell Transplant)
Description:
Pre-allo reduced intensity chemotherapy vadastuximab talirine (melphalan and fludarabine)
Fludarabine: 30 mg/m2/day intravenously, 5 to 2 days before the transplant (total dose of 120 mg/m2)
Melphalan: Melphalan 140 mg/m2 intravenously, 2 days before the transplant
vadastuximab talirine: Pre-allo (before stem cell transplant) given 14 days before the stem cell transplant
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
6
Other Number Affected:
6
Other Number At Risk:
6
Study:
NCT02614560
Results Section:
NCT02614560
Adverse Events Module:
NCT02614560